Literature DB >> 34128977

SIRT7 restricts HBV transcription and replication through catalyzing desuccinylation of histone H3 associated with cccDNA minichromosome.

Hai-Bo Yu1, Sheng-Tao Cheng1, Fang Ren1, Yong Chen2, Xiao-Feng Shi3, Vincent Kam Wai Wong4, Betty Yuen Kwan Law4, Ji-Hua Ren1, Shan Zhong5, Wei-Xian Chen6, Hong Mei Xu7, Zhen Zhen Zhang7, Jie Li Hu5, Xue Fei Cai5, Yuan Hu5, Wen Lu Zhang5, Quan-Xin Long3, Lin He5, Zhong Wen Hu5, Hui Jiang5, Hong Zhong Zhou5, Ai-Long Huang1, Juan Chen5.   

Abstract

Chronic HBV infection is a significant public health burden worldwide. HBV cccDNA organized as a minichromosome in nucleus is responsible for viral persistence and is the key obstacle for a cure of chronic hepatitis B. Recent studies suggest cccDNA transcription is epigenetically regulated by histone modifications, especially histone acetylation and methylation. In this study, we identified transcriptionally active histone succinylation (H3K122succ) as a new histone modification on cccDNA minichromosome by using cccDNA ChIP-Seq approach. SIRT7, as a NAD+-dependent histone desuccinylase, could bind to cccDNA through interaction with HBV core protein where it catalysed histone H3K122 desuccinylation. Moreover, SIRT7 acts cooperatively with histone methyltransferase SUV39H1 and SETD2 to induce silencing of HBV transcription through modulation of chromatin structure. Our data improved the understanding of histone modifications of the cccDNA minichromosome, thus transcriptional silencing of cccDNA may represent a novel antiviral strategy for the prevention or treatment of HBV infection. Copyright 2021 The Author(s).

Entities:  

Keywords:  Hepatitis B virus; Histone desuccinylase; Histone methylation; Sirtuin 7; cccDNA minichromosome

Year:  2021        PMID: 34128977     DOI: 10.1042/CS20210392

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters.

Authors:  Dai-Qing Wu; Qiu-Ying Ding; Na-Na Tao; Ming Tan; Yuan Zhang; Fan Li; Yu-Jiao Zhou; Mei-Ling Dong; Sheng-Tao Cheng; Fang Ren; Juan Chen; Ji-Hua Ren
Journal:  Front Microbiol       Date:  2022-05-19       Impact factor: 6.064

2.  KAT2A Promotes Hepatitis B Virus Transcription and Replication Through Epigenetic Regulation of cccDNA Minichromosome.

Authors:  Yi-Ping Qin; Hai-Bo Yu; Si-Yu Yuan; Zhen Yang; Fang Ren; Qing Wang; Fan Li; Ji-Hua Ren; Sheng-Tao Cheng; Yu-Jiao Zhou; Xin He; Hong-Zhong Zhou; Yuan Zhang; Ming Tan; Min-Li Yang; Da-Peng Zhang; Xu Wen; Mei-Ling Dong; Hui Zhang; Jing Liu; Zhi-Hong Li; Yao Chen; Ai-Long Huang; Wei-Xian Chen; Juan Chen
Journal:  Front Microbiol       Date:  2022-01-24       Impact factor: 5.640

Review 3.  HBV cccDNA-A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure.

Authors:  Sajad Ahmad Bhat; Syed Naqui Kazim
Journal:  ACS Omega       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.